Work

Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?

Year: 2006

Type: article

Study design: Observational Study

Source: American Journal of Obstetrics and Gynecology

DOI: 10.1016/j.ajog.2006.06.006

Authors: Christine H. Comstock, Fergal D. Malone, Robert H. Ball, David A. Nyberg, George R. Saade, Richard L. Berkowitz, Jose Ferreira, Lorraine Dugoff, Sabrina D. Craigo, Ilan E. Timor-Tritsch, Stephen R. Carr, Honor M. Wolfe, Diana W. Bianchi, Mary E. D'Alton

Institutions: Corewell Health William Beaumont University Hospital, Royal College of Surgeons in Ireland, Columbia University, Intermountain Healthcare, University of California, San Francisco, University of Utah, Swedish Medical Center, The University of Texas Medical Branch at Galveston, Icahn School of Medicine at Mount Sinai, Albert Einstein College of Medicine, Montefiore Medical Center, University of Colorado Denver, Tufts University, New York University, Brown University, University of North Carolina at Chapel Hill, University of North Carolina Hospitals

Language: English

Topic: Prenatal Screening and Diagnostics

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: FIRST AND SECOND TRIMESTER EVALUATION OF ANEUPLOIDY RISK, GENERAL CLINICAL RESEARCH CENTER

OpenAlex ID: W1988360253

FWCI: 5.597

Cites: 10

Cited by: 62

Related to: 10